Related Experiment Video
Updated: Jul 16, 2026

Candida albicans Biofilm Development on Medically-relevant Foreign Bodies in a Mouse Subcutaneous Model Followed by Bioluminescence Imaging
Published on: January 27, 2015
Biofilm Formation and Aspartyl Proteinase Activity and Their Association with Azole Resistance Among Candida albicans
Marian A Gerges1, Yasmin Ahmed Fahmy1, Thoraya Hosny2
1Medical Microbiology and Immunology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Background:
Candida albicans (C. albicans) is a major cause of vulvovaginal candidiasis (VVC), a condition that is commonly treated with azole agents. Biofilm formation and aspartyl proteinase production are important virulence factors that could be linked to azole resistance in C. albicans impeding therapy.
Aim:
To find out the association of both factors with azole resistance among C. albicans isolated from VVC cases in Egyptian nonpregnant women of childbearing age.
Patients And Methods:
In a cross-sectional study, C. albicans was isolated from nonpregnant females diagnosed clinically as having VVC during a 1-year study period. Susceptibility to azole agents was tested using the disc diffusion method. Biofilm formation and aspartyl proteinase production were assessed phenotypically. Additionally, two biofilm-related genes (ALS1 and HWP1) and three proteinase genes (SAP2, SAP4, and SAP6) were screened for using polymerase chain reaction (PCR).
Results:
Among 204 C. albicans isolates, azole resistance ratios were as follows: voriconazole (30.4%), itraconazole (17.6%), fluconazole (11.3%) and econazole (6.4%). Biofilm-producing capacity was detected in 63.2% of isolates, and 63.2% were proteinase producers. The frequencies of ALS1 and HWP1 were 69.6% and 74.5%, respectively, while SAP2, SAP4, and SAP6 were 69.2%, 88.7%, and 64.7%, respectively. Biofilm formation was significantly associated with azole resistance (P < 0.001 for each tested azole agent) as was proteinase production (P < 0.001 for fluconazole, voriconazole, and econazole resistance and P = 0.047 for itraconazole).
Conclusion:
Among nonpregnant Egyptian women of childbearing age, azole resistance in C. albicans causing VVC is significantly associated with biofilm formation and proteinase production. The development of new therapeutic agents that can target these factors is warranted.
Insights
Azole resistance in Candida albicans causing vulvovaginal candidiasis is linked to biofilm formation and proteinase production in Egyptian women. New therapies targeting these virulence factors are needed.
Area of Science:
- Mycology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Candida albicans is a primary cause of vulvovaginal candidiasis (VVC).
- Azole agents are common VVC treatments.
- Biofilm formation and aspartyl proteinase production are virulence factors potentially linked to azole resistance in C. albicans.
Purpose of the Study:
- To investigate the association between biofilm formation, proteinase production, and azole resistance in C. albicans isolates from Egyptian women with VVC.
Main Methods:
- Cross-sectional study of 204 C. albicans isolates from nonpregnant women with VVC.
- Azole susceptibility testing using disc diffusion.
- Phenotypic assessment of biofilm formation and proteinase production.
- PCR screening for biofilm-related genes (ALS1, HWP1) and proteinase genes (SAP2, SAP4, SAP6).
Main Results:
- High azole resistance rates observed: voriconazole (30.4%), itraconazole (17.6%), fluconazole (11.3%), econazole (6.4%).
- 63.2% of isolates exhibited biofilm-producing capacity and 63.2% were proteinase producers.
- Significant association found between biofilm formation and azole resistance (P < 0.001).
- Significant association found between proteinase production and resistance to fluconazole, voriconazole, econazole (P < 0.001), and itraconazole (P = 0.047).
Conclusions:
- Azole resistance in C. albicans causing VVC in nonpregnant Egyptian women is significantly associated with biofilm formation and proteinase production.
- These findings highlight the clinical relevance of these virulence factors in treatment failure.
- Development of novel therapeutic strategies targeting biofilm and proteinase may be beneficial.
More Related Videos
Related Concept Videos
Biofilms
Fungal Phylum Ascomycota
Candidiasis
Antifungal Agents

